Univariate | Multivariate | |||||
HR | 95% CI | P value | HR | 95% CI | P value | |
Age (per 1-year increase) | 1.03 | 0.97 to 1.10 | 0.279 | |||
Male | 1.32 | 0.72 to 2.40 | 0.372 | |||
NYHA class 3 or 4 | 1.17 | 0.66 to 2.09 | 0.595 | |||
DM | 1.15 | 0.63 to 2.09 | 0.650 | |||
Dyslipidaemia | 0.72 | 0.40 to 1.31 | 0.289 | |||
Hypertension | 1.93 | 0.82 to 4.56 | 0.133 | |||
CKD | 1.63 | 0.83 to 3.21 | 0.159 | |||
Atrial fibrillation | 1.70 | 0.94 to 3.06 | 0.077 | |||
PAD | 1.74 | 0.90 to 3.37 | 0.098 | |||
COPD | 1.38 | 0.71 to 2.67 | 0.338 | |||
BNP pg/mL (per 100 pg/mL increase) | 1.04 | 1.00 to 1.07 | 0.038 | 1.06 | 1.01 to 1.11 | 0.025 |
STS score (per 1 U increase) | 1.03 | 1.00 to 1.06 | 0.022 | |||
Transapical approach | 1.52 | 0.80 to 2.89 | 0.199 | |||
TTE (pre-TAVI) | ||||||
LAD, mm (per 1 mm increase) | 1.04 | 1.00 to 1.08 | 0.043 | |||
AVA, cm2 (per 0.1 cm2 decrease) | 0.96 | 0.78 to 1.17 | 0.672 | |||
MG, mm Hg (per 10 mm Hg decrease) | 1.68 | 1.08 to 2.61 | 0.020 | |||
SVi, mL/m2 (per 10 mL/m2 decrease) | 1.25 | 0.96 to 1.63 | 0.094 | |||
LVEF, % (per 10% decrease) | 1.23 | 1.02 to 1.50 | 0.033 | |||
Moderate-severe AR | 0.22 | 0.03 to 1.62 | 0.054 | |||
Moderate-severe MR | 2.97 | 1.47 to 5.99 | 0.002 | 2.71 | 1.26 to 5.82 | 0.011 |
TTE (post-TAVI) | ||||||
EOA, cm2 (per 0.1 cm2 decrease) | 1.06 | 0.99 to 1.15 | 0.111 | |||
MG, mm Hg (per 10 mm Hg decrease) | 2.89 | 1.11 to 7.46 | 0.029 | |||
SVi, mL/m2 (per 10 mL/m2 decrease) | 1.47 | 1.16 to 1.87 | 0.001 | 1.35 | 1.03 to 1.76 | 0.028 |
LVEF, % (per 10% decrease) | 1.30 | 1.05 to 1.61 | 0.015 | |||
Moderate-severe PVL | 1.60 | 0.22 to 11.6 | 0.642 | |||
Moderate-severe MR | 2.40 | 1.08 to 5.38 | 0.033 |
AR, aortic regurgitation; AVA, aortic valve area; BNP, brain natriuretic peptide; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; EOA, effective orifice area; LAD, left atrial diameter; LVEF, left ventricular ejection fraction; MG, mean pressure gradient; MR, mitral regurgitation; NYHA, New York Heart Association; PAD, peripheral artery disease; PVL, paravalvular leakage; STS, Society of Thoracic Surgeons' risk model; SVi, stroke volume index; TAVI, transcatheter aortic valve implantation; TTE, transthoracic echocardiography.